Andrew Tsai
Stock Analyst at Jefferies
(0)
# 4983
Out of 5,329 analysts
22
Total ratings
20.00%
Success rate
-31.84%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics | Initiates Coverage On: Buy | 200 | 113.17 | 76.73% | 1 | Apr 7, 2025 | |
BEKE KE Holdings | Maintains: Overweight | 19 27 | 21.06 | 28.21% | 2 | Mar 19, 2025 | |
RCKT Rocket Pharmaceutica... | Initiates Coverage On: Buy | 29 | 8.12 | 257.14% | 1 | Dec 18, 2024 | |
MRNS Marinus Pharma | Downgrades: Hold | 5 1 | n/a | n/a | 1 | Oct 25, 2024 | |
SRPT Sarepta Therapeutics | Initiates Coverage On: Buy | 165 | 63.8 | 158.62% | 1 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 4 13 | 0.37 | 3413.51% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 12.07 | 189.98% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 21 | n/a | n/a | 1 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 33 | 2.5 | 1220% | 1 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 1 15 | 2.38 | 530.25% | 2 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 3 | 0.72 | 316.67% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 32 3 | 0.29 | 934.48% | 2 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | 2.56 | 681.25% | 1 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 70 | n/a | n/a | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 27 | 1.5 | 1700% | 1 | Sep 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | n/a | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 16 23 | 38.2 | -39.79% | 1 | Jun 1, 2020 |